References
1. Munoz FM. Pertussis in infants, children, and adolescents: diagnosis,
treatment, and prevention. Semin Pediatr Infect Dis. 2006;17(1):14-9.
2. Cortese MM, Baughman AL, Zhang R, Srivastava PU, Wallace GS.
Pertussis hospitalizations among infants in the United States, 1993 to
2004. Pediatrics. 2008;121(3):484-92.
3. Quinn HE, McIntyre PB. Pertussis epidemiology in Australia over the
decade 1995-2005–trends by region and age group. Communicable
diseases intelligence quarterly report. 2007;31(2):205-15.
4. Wiley KE, Zuo Y, Macartney KK, McIntyre PB. Sources of pertussis
infection in young infants: a review of key evidence informing targeting
of the cocoon strategy. Vaccine. 2013;31(4):618-25.
5. Amirthalingam G. Strategies to control pertussis in infants. Arch Dis
Child. 2013;98(7):552-5.
6. Amirthalingam G, Andrews N, Campbell H, Ribeiro S, Kara E, Donegan K,
et al. Effectiveness of maternal pertussis vaccination in England: an
observational study. Lancet. 2014;384(9953):1521-8.
7. Baxter R, Bartlett J, Fireman B, Lewis E, Klein NP. Effectiveness of
Vaccination During Pregnancy to Prevent Infant Pertussis. Pediatrics.
2017;139(5).
8. Mohammed H, McMillan M, Roberts CT, Marshall HS. A systematic review
of interventions to improve uptake of pertussis vaccination in
pregnancy. PLoS One. 2019;14(3):e0214538.
9. Wilson RJ, Paterson P, Jarrett C, Larson HJ. Understanding factors
influencing vaccination acceptance during pregnancy globally: A
literature review. Vaccine. 2015;33(47):6420-9.
10. MacDougall DM, Halperin SA. Improving rates of maternal
immunization: Challenges and opportunities. Hum Vaccin Immunother.
2016;12(4):857-65.
11. Furuta M, Sin J, Ng ESW, Wang K. Efficacy and safety of pertussis
vaccination for pregnant women - a systematic review of randomised
controlled trials and observational studies. BMC Pregnancy Childbirth.
2017;17(1):390-.
12. McMillan M, Clarke M, Parrella A, Fell DB, Amirthalingam G, Marshall
HS. Safety of Tetanus, Diphtheria, and Pertussis Vaccination During
Pregnancy: A Systematic Review. Obstet Gynecol. 2017;129(3):560-73.
13. Vygen-Bonnet S, Hellenbrand W, Garbe E, von Kries R, Bogdan C,
Heininger U, et al. Safety and effectiveness of acellular pertussis
vaccination during pregnancy: a systematic review. BMC Infect Dis.
2020;20(1):136.
14. D’Heilly C, Switzer C, Macina D. Safety of Maternal Immunization
Against Pertussis: A Systematic Review. Infectious Diseases and Therapy.
2019;8(4):543-68.
15. Kharbanda EO, Vazquez-Benitez G, Lipkind HS, et al. Evaluation of
the association of maternal pertussis vaccination with obstetric events
and birth outcomes. JAMA. 2014;312(18):1897-904.
16. Layton JB, Butler AM, Li D, Boggess KA, Weber DJ, McGrath LJ, et al.
Prenatal Tdap immunization and risk of maternal and newborn adverse
events. Vaccine. 2017;35(33):4072-8.
17. DeSilva M, Vazquez-Benitez G, Nordin JD, Lipkind HS, Klein NP,
Cheetham TC, et al. Maternal Tdap vaccination and risk of infant
morbidity. Vaccine. 2017;35(29):3655-60.
18. Johnson CT, Farzin A, Burd I. Current management and long-term
outcomes following chorioamnionitis. Obstet Gynecol Clin North Am.
2014;41(4):649-69.
19. Australian New Zealand Clinical Trials Registry: Screening Tests to
identify poor Outcomes in Pregnancy (STOP) Study 2014. Registration
number ACTRN12614000985684. [cited 01/09/2020]. Available from:
https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=366996.
20. Mohammed H, Roberts CT, Grzeskowiak LE, Giles L, Leemaqz S, Dalton
J, et al. Psychosocial determinants of pertussis and influenza vaccine
uptake in pregnant women: A prospective study. Vaccine.
2020;38(17):3358-68.
21. Munoz FM, Eckert LO, Katz MA, Lambach P, Ortiz JR, Bauwens J, et al.
Key terms for the assessment of the safety of vaccines in pregnancy:
Results of a global consultative process to initiate harmonization of
adverse event definitions. Vaccine. 2015;33(47):6441-52.
22. Jones CE, Munoz FM, Kochhar S, Vergnano S, Cutland CL, Steinhoff M,
et al. Guidance for the collection of case report form variables to
assess safety in clinical trials of vaccines in pregnancy. Vaccine.
2016;34(49):6007-14.
23. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived
stress. J Health Soc Behav. 1983;24(4):385-96.
24. Marteau TM, Bekker H. The development of a six-item short-form of
the state scale of the Spielberger State-Trait Anxiety Inventory (STAI).
Br J Clin Psychol. 1992;31 ( Pt 3):301-6.
25. Cox JL, Holden JM, Sagovsky R. Detection of postnatal depression.
Development of the 10-item Edinburgh Postnatal Depression Scale. Br J
Psychiatry. 1987;150:782-6.
26. Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O’Neal L, et
al. The REDCap consortium: Building an international community of
software platform partners. J Biomed Inform. 2019;95:103208.
27. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG.
Research electronic data capture (REDCap)–a metadata-driven
methodology and workflow process for providing translational research
informatics support. J Biomed Inform. 2009;42(2):377-81.
28. Hutcheon JA, Savitz DA. Invited Commentary: Influenza, Influenza
Immunization, and Pregnancy-It’s About Time. Am J Epidemiol.
2016;184(3):187-91.
29. Senn SJ. Power is indeed irrelevant in interpreting completed
studies. BMJ (Clinical research ed). 2002;325(7375):1304-.
30. Hoenig JM, Heisey DM. The Abuse of Power. The American Statistician.
2001;55(1):19-24.
31. The Australian Government Department of Health and Ageing.
Australian Technical Advisory Group on Immunisation Canberra2019.
32. Hyman J. The limitations of using insurance data for research. J Am
Dent Assoc. 2015;146(5):283-5.